Publications found:
1,234
Sort by:
Chronic Myeloid Leukemia (Cml) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy, Stem Cell Transplant), By Drug Type (Tyrosine Kinase Inhibitors, Antimetabolites, Other Drug Types), By Application, By Distribution Channel
US$ 3,950.00
The Chronic Myeloid Leukemia (Cml) Treatment Market is valued at USD 10.7 billion in 2025 and is projected to grow at a CAGR of 5.5% to reach USD 17.3 billion by 2034.The chronic myeloid leukemia (CML...
October 2025
160 pages
Endometrial Cancer Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Adenocarcinoma, Uterine Carcinosarcoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Transitional Carcinoma, Serous Carcinoma, Other Types), By Diagnosis Method (Biopsy, Pelvic Ultrasound, Hysteroscopy, CT Scan, Other Diagnosis Methods), By Route Of Administration, By Distribution Channel
US$ 3,950.00
The Endometrial Cancer Treatment Market is valued at USD 27.7 billion in 2025 and is projected to grow at a CAGR of 4.8% to reach USD 42.1 billion by 2034. Market Overview: Endometrial Cancer Treatmen...
October 2025
160 pages
Poly Adp-Ribose Polymerase (Parp) Inhibitor Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Talazoparib, Veliparib, Olaparib, Other Drug Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels), By Application, By End Users
US$ 3,950.00
The Poly Adp-Ribose Polymerase (Parp) Inhibitor Market is valued at USD 8.8 billion in 2025 and is projected to grow at a CAGR of 10.8% to reach USD 22.1 billion by 2034. Poly ADP-Ribose Polymerase (P...
October 2025
160 pages
Proteasome Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Velcade, Kyprolis, Ninlaro, Other Products), By Drugs (Bortezomib, Carfilzomib, Ixazomib), By Indication, By Distribution Channel, By End-User
US$ 3,950.00
The Proteasome Inhibitors Market is valued at USD 2.6 billion in 2025 and is projected to grow at a CAGR of 8.8% to reach USD 5.6 billion by 2034. Proteasome Inhibitors Market Overview The proteasome...
October 2025
160 pages
Acute Myeloid Leukemia Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment Type (Chemotherapy, Radiation therapy, Stem Cell Transplant, Targeted Therapy), By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy), By Regimen, By End-User
US$ 3,950.00
The Acute Myeloid Leukemia Market is valued at USD 3.1 billion in 2025 and is projected to grow at a CAGR of 9.1% to reach USD 6.8 billion by 2034.The acute myeloid leukemia (AML) market is a speciali...
October 2025
160 pages
Anthracycline Market Outlook 2025-2034: Market Share, and Growth Analysis By Drugs (Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mitoxantrone, Valrubicin), By Dosage (Powder, Capsule, Solution, Injection, Suspension, Other Dosages), By Application, By End User
US$ 3,950.00
The Anthracycline Market is valued at USD 2 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 4.1 billion by 2034. Anthracycline Market The Anthracycline Market is expanding nota...
October 2025
160 pages
Anti-Cancer Mabs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Murine Antibodies, Chimeric Antibodies, Humanized Antibodies, Other Types), By Application (Blood Cancer, Breast Cancer, Lung Cancer, Melanoma, Colorectal Cancer, Liver Cancer, Other Applications), By End User
US$ 3,950.00
The Anti-Cancer Mabs Market is valued at USD 62.6 billion in 2025 and is projected to grow at a CAGR of 8.8% to reach USD 133.4 billion by 2034.The Anti-Cancer Monoclonal Antibodies (MAbS) Market is a...
October 2025
160 pages
Anti-Neoplastic Agents Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Alkylating Agents, Antimetabolites, Hormones And Antagonists, Miscellaneous), By Disease Type (Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Other Disease Types), By End User
US$ 3,950.00
The Anti-Neoplastic Agents Market is valued at USD 127.3 billion in 2025 and is projected to grow at a CAGR of 9.4% to reach USD 285.5 billion by 2034.The Anti-Neoplastic Agents Market focuses on the...
October 2025
160 pages
Blood Cancer Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches
US$ 3,950.00
The Blood Cancer Drugs Market is valued at USD 67.1 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 138.9 billion by 2034.The Blood Cancer Drugs Market is experiencing substant...
October 2025
160 pages
Breast Cancer Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By End User
US$ 3,950.00
The Breast Cancer Drugs Market is valued at USD 38.8 billion in 2025 and is projected to grow at a CAGR of 8.3% to reach USD 79.3 billion by 2034.The breast cancer drugs market represents one of the m...
October 2025
160 pages
Cancer Monoclonal Antibodies Market Outlook 2025-2034: Market Share, and Growth Analysis By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain Tumor, Colorectal Cancer, Cervical Cancer, Gastric Cancer, Others), By End-User
US$ 3,950.00
The Cancer Monoclonal Antibodies Market is valued at USD 61.2 billion in 2025 and is projected to grow at a CAGR of 10.4% to reach USD 149.1 billion by 2034. Cancer Monoclonal Antibodies Market The ca...
October 2025
160 pages
Cytotoxic Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Alkylating Agents, Antitumor Antibiotics, Antimetabolites, Plant Alkaloids, Other Drug Types), By Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, Other Therapies), By Application, By End User
US$ 3,950.00
The Cytotoxic Drugs Market is valued at USD 13.6 billion in 2025 and is projected to grow at a CAGR of 5% to reach USD 21.2 billion by 2034.The cytotoxic drugs market plays a critical role in cancer t...
October 2025
160 pages
Follicular Lymphoma Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment (Monoclonal Antibodies, Targeted Therapy, Chemotherapy, Radiation Therapy, Stem Cell Transplant, Alkylating Agents, Nucleoside Analogues, Anthracycline Derivatives, Other Treatments), By Product Type (Tablets, Capsules, Injectables, Other Product Types), By Route of Administration, By End Use
US$ 3,950.00
The Follicular Lymphoma Treatment Market is valued at USD 3.9 billion in 2025 and is projected to grow at a CAGR of 10.4% to reach USD 9.5 billion by 2034.The Follicular Lymphoma Treatment Market is a...
October 2025
160 pages
Gastric Cancer Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), By End User (Hospitals, Clinics), By Route of Administration
US$ 3,950.00
The Gastric Cancer Drugs Market is valued at USD 5.9 billion in 2025 and is projected to grow at a CAGR of 12.3% to reach USD 16.7 billion by 2034. Gastric Cancer Drugs Market Overview The Gastric Can...
October 2025
160 pages
Gynecological Cancer Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Alkylating Agent, Plant Alkaloid, Anthracyclines, Antitumor Antibiotic, Other Types), By Therapeutic Modality (Chemotherapy, Targeted Therapy, Hormonal Therapy), By Indication, By End Users
US$ 3,950.00
The Gynecological Cancer Drugs Market is valued at USD 14.3 billion in 2025 and is projected to grow at a CAGR of 6.8% to reach USD 25.8 billion by 2034.The gynecological cancer drugs market has gaine...
October 2025
160 pages
Immuno-Oncology Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others), By Therapeutic Application (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application), By End-Users
US$ 3,950.00
The Immuno-Oncology Drugs Market is valued at USD 103.5 billion in 2025 and is projected to grow at a CAGR of 15% to reach USD 364.4 billion by 2034.The Immuno-Oncology Drugs Market is a rapidly evolv...
October 2025
160 pages
Intratumoral Cancer Therapies Market Outlook 2025-2034: Market Share, and Growth Analysis By Technology (Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Cell Therapies, Immunes System Modulator, Adoptive Cell Transfer, Cytokines ), By Application (Lung Cancer, Breast Cancer, Melanoma, Prostate Cancer, Head and Neck Cancer, Other Applications ), By End Users
US$ 3,950.00
The Intratumoral Cancer Therapies Market is valued at USD 136.4 billion in 2025 and is projected to grow at a CAGR of 12.3% to reach USD 388.4 billion by 2034.The Intratumoral Cancer Therapies Market...
October 2025
160 pages
Kinase Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Tyrosine Kinase Inhibitors, Multikinase Inhibitors, mTOR Kinase Inhibitors, Other Types), By Route of Administration (Oral, Parenteral, Other Routes), By Application, By Distribution Channel, By End User
US$ 3,950.00
The Kinase Inhibitors Market is valued at USD 57.2 billion in 2025 and is projected to grow at a CAGR of 7.9% to reach USD 113.2 billion by 2034.The Kinase Inhibitors Market focuses on a class of drug...
October 2025
160 pages
Lenalidomide Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (5Mg Capsules, 10Mg Capsules, 15Mg Capsules, 25Mg Capsules), By Application (Multiple Myeloma (MM), Myelodysplastic Syndromes (MDS), Lymphoma, Other Applications), By End-User
US$ 3,950.00
The Lenalidomide Market is valued at USD 10.5 billion in 2025 and is projected to grow at a CAGR of 6.9% to reach USD 19.2 billion by 2034.The lenalidomide market centers around a key immunomodulatory...
October 2025
160 pages
Leukemia Therapeutics Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Other Type Of Leukemia), By Molecule Type, By End-Users
US$ 3,950.00
The Leukemia Therapeutics Market is valued at USD 16.6 billion in 2025 and is projected to grow at a CAGR of 7% to reach USD 30.6 billion by 2034.The leukemia therapeutics market comprises a range of...
October 2025
160 pages
Lung Cancer Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)), By End User
US$ 3,950.00
The Lung Cancer Drugs Market is valued at USD 45.2 billion in 2025 and is projected to grow at a CAGR of 11% to reach USD 115.7 billion by 2034.The lung cancer drugs market addresses one of the most p...
October 2025
160 pages
Mantle Cell Lymphoma Therapeutics Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Combination Therapy, Monotherapy), By Mechanism of Action (Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms), By Route of Administration, By Application
US$ 3,950.00
The Mantle Cell Lymphoma Therapeutics Market is valued at USD 3.3 billion in 2025 and is projected to grow at a CAGR of 8.7% to reach USD 7 billion by 2034.The Mantle Cell Lymphoma (MCL) therapeutics...
October 2025
160 pages
Melanoma Therapeutics Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Monoclonal Antibodies, Small Molecule Inhibitors, Other Drug Types), By Therapy (Surgery, Radiation Therapy, Immunotherapy, Targeted Therapy, Chemotherapy), By Route of administration, By Cancer Type, By Diagnosis
US$ 3,950.00
The Melanoma Therapeutics Market is valued at USD 5.3 billion in 2025 and is projected to grow at a CAGR of 11.6% to reach USD 14.2 billion by 2034.The Melanoma Therapeutics Market is a highly dynamic...
October 2025
160 pages
Pd-1 And Pdl1 Inhibitors/ Immune Checkpoint Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Application, By End-Users
US$ 3,950.00
The Pd-1 And Pdl1 Inhibitors/ Immune Checkpoint Inhibitors Market is valued at USD 46.8 billion in 2025 and is projected to grow at a CAGR of 16.1% to reach USD 179.9 billion by 2034.The global PD-1 a...
October 2025
160 pages
Small Cell Lung Cancer Therapeutics Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate, Pembrolizumab), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Route Of Administration, By End-Users
US$ 3,950.00
The Small Cell Lung Cancer Therapeutics Market is valued at USD 9.2 billion in 2025 and is projected to grow at a CAGR of 13.1% to reach USD 27.9 billion by 2034.The small cell lung cancer (SCLC) ther...
October 2025
160 pages
Thyroid Cancer Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Other Drug Types), By Type (Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Other Types), By End Users
US$ 3,950.00
The Thyroid Cancer Drugs Market is valued at USD 1.5 billion in 2025 and is projected to grow at a CAGR of 13.5% to reach USD 4.7 billion by 2034.The Thyroid Cancer Drugs Market has gained significant...
October 2025
160 pages
Global Ovarian Cancer Treatment Drugs Market Growth 2025-2031
US$ 3,660.00
... forecast to 2023. To understand the structure of Ovarian Cancer Treatment Drugs market by identifying its various subsegments. Focuses on the key global Ovarian Cancer Treatment Drugs manufacturers, to define, describe and analyze ...
October 2025
89 pages
Global Megestrol Market Growth 2025-2031
US$ 3,660.00
... global market share (sales and revenue) of key companies in Megestrol business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Megestrol market ... breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7. Injection ...
October 2025
111 pages
Global Temozolomide Market Growth 2025-2031
US$ 3,660.00
The global Temozolomide market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff m...
October 2025
93 pages
